 | • レポートコード：GIR-105X10298 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Chemical & Material |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、レボドパのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。レボドパの種類別市場規模（0.98、0.99、その他）、用途別市場規模（製薬業界、栄養補助食品）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・レボドパの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Xi'an Lyphar Biotech、Hindustan Herbals、Xi'an ZB Biotech、Xi'an Arisun ChemPharm、Hunan Nutramax ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：0.98、0.99、その他 ・用途別分析2016年-2026年：製薬業界、栄養補助食品 ・レボドパの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・レボドパのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・レボドパのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・レボドパの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・レボドパの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Levodopa market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Levodopa size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Levodopa market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Levodopa market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0.98
0.99
Others
Market segment by Application can be divided into
Pharmaceuticals Industry
Dietary Supplements
The key market players for global Levodopa market are listed below:
Xi’an Lyphar Biotech
Hindustan Herbals
Xi’an ZB Biotech
Xi’an Arisun ChemPharm
Hunan Nutramax
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Levodopa Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Levodopa Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Levodopa Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pharmaceuticals Industry
1.3.3 Dietary Supplements
1.4 Global Levodopa Market Size & Forecast
1.4.1 Global Levodopa Sales in Value (2016-2026))
1.4.2 Global Levodopa Sales in Volume (2016-2026)
1.4.3 Global Levodopa Price by Type (2016-2026) & (USD/Kg)
1.5 Global Levodopa Production Capacity Analysis
1.5.1 Global Levodopa Total Production Capacity (2016-2026)
1.5.2 Global Levodopa Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Levodopa Market Drivers
1.6.2 Levodopa Market Restraints
1.6.3 Levodopa Trends Analysis
2 Manufacturers Profiles
2.1 Xi’an Lyphar Biotech
2.1.1 Xi’an Lyphar Biotech Details
2.1.2 Xi’an Lyphar Biotech Major Business
2.1.3 Xi’an Lyphar Biotech Levodopa Product and Services
2.1.4 Xi’an Lyphar Biotech Levodopa Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Hindustan Herbals
2.2.1 Hindustan Herbals Details
2.2.2 Hindustan Herbals Major Business
2.2.3 Hindustan Herbals Levodopa Product and Services
2.2.4 Hindustan Herbals Levodopa Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Xi’an ZB Biotech
2.3.1 Xi’an ZB Biotech Details
2.3.2 Xi’an ZB Biotech Major Business
2.3.3 Xi’an ZB Biotech Levodopa Product and Services
2.3.4 Xi’an ZB Biotech Levodopa Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Xi’an Arisun ChemPharm
2.4.1 Xi’an Arisun ChemPharm Details
2.4.2 Xi’an Arisun ChemPharm Major Business
2.4.3 Xi’an Arisun ChemPharm Levodopa Product and Services
2.4.4 Xi’an Arisun ChemPharm Levodopa Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Hunan Nutramax
2.5.1 Hunan Nutramax Details
2.5.2 Hunan Nutramax Major Business
2.5.3 Hunan Nutramax Levodopa Product and Services
2.5.4 Hunan Nutramax Levodopa Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Levodopa Sales by Manufacturer
3.1 Global Levodopa Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Levodopa Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Levodopa
3.4 Market Concentration Rate
3.4.1 Top 3 Levodopa Manufacturer Market Share
3.4.2 Top 6 Levodopa Manufacturer Market Share
3.5 Global Levodopa Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Levodopa Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Levodopa Market Size by Region
4.1.1 Global Levodopa Sales in Volume by Region (2016-2026)
4.1.2 Global Levodopa Revenue by Region (2016-2026)
4.2 North America Levodopa Revenue (2016-2026)
4.3 Europe Levodopa Revenue (2016-2026)
4.4 Asia-Pacific Levodopa Revenue (2016-2026)
4.5 South America Levodopa Revenue (2016-2026)
4.6 Middle East and Africa Levodopa Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Levodopa Sales in Volume by Type (2016-2026)
5.2 Global Levodopa Revenue by Type (2016-2026)
5.3 Global Levodopa Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Levodopa Sales in Volume by Application (2016-2026)
6.2 Global Levodopa Revenue by Application (2016-2026)
6.3 Global Levodopa Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Levodopa Sales by Type (2016-2026)
7.2 North America Levodopa Sales by Application (2016-2026)
7.3 North America Levodopa Market Size by Country
7.3.1 North America Levodopa Sales in Volume by Country (2016-2026)
7.3.2 North America Levodopa Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Levodopa Sales by Type (2016-2026)
8.2 Europe Levodopa Sales by Application (2016-2026)
8.3 Europe Levodopa Market Size by Country
8.3.1 Europe Levodopa Sales in Volume by Country (2016-2026)
8.3.2 Europe Levodopa Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Levodopa Sales by Type (2016-2026)
9.2 Asia-Pacific Levodopa Sales by Application (2016-2026)
9.3 Asia-Pacific Levodopa Market Size by Region
9.3.1 Asia-Pacific Levodopa Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Levodopa Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Levodopa Sales by Type (2016-2026)
10.2 South America Levodopa Sales by Application (2016-2026)
10.3 South America Levodopa Market Size by Country
10.3.1 South America Levodopa Sales in Volume by Country (2016-2026)
10.3.2 South America Levodopa Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Levodopa Sales by Type (2016-2026)
11.2 Middle East & Africa Levodopa Sales by Application (2016-2026)
11.3 Middle East & Africa Levodopa Market Size by Country
11.3.1 Middle East & Africa Levodopa Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Levodopa Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Levodopa Typical Distributors
12.3 Levodopa Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Levodopa Revenue by Type, (USD Million), 2021-2026
Table 2. Global Levodopa Revenue by Application, (USD Million), 2021-2026
Table 3. Xi'an Lyphar Biotech Basic Information, Manufacturing Base and Competitors
Table 4. Xi'an Lyphar Biotech Major Business
Table 5. Xi'an Lyphar Biotech Levodopa Product and Services
Table 6. Xi'an Lyphar Biotech Levodopa Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Hindustan Herbals Basic Information, Manufacturing Base and Competitors
Table 8. Hindustan Herbals Major Business
Table 9. Hindustan Herbals Levodopa Product and Services
Table 10. Hindustan Herbals Levodopa Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Xi'an ZB Biotech Basic Information, Manufacturing Base and Competitors
Table 12. Xi'an ZB Biotech Major Business
Table 13. Xi'an ZB Biotech Levodopa Product and Services
Table 14. Xi'an ZB Biotech Levodopa Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Xi'an Arisun ChemPharm Basic Information, Manufacturing Base and Competitors
Table 16. Xi'an Arisun ChemPharm Major Business
Table 17. Xi'an Arisun ChemPharm Levodopa Product and Services
Table 18. Xi'an Arisun ChemPharm Levodopa Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hunan Nutramax Basic Information, Manufacturing Base and Competitors
Table 20. Hunan Nutramax Major Business
Table 21. Hunan Nutramax Levodopa Product and Services
Table 22. Hunan Nutramax Levodopa Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Levodopa Sales by Manufacturer (2019-2021e) & (MT)
Table 24. Global Levodopa Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Levodopa, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Levodopa Production Capacity by Company, (MT): 2020 VS 2021
Table 27. Head Office and Levodopa Production Site of Key Manufacturer
Table 28. Global Levodopa Sales by Region (2016-2021e) & (MT)
Table 29. Global Levodopa Sales by Region (2021-2026) & (MT)
Table 30. Global Levodopa Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Levodopa Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Levodopa Sales by Type (2016-2021e) & (MT)
Table 33. Global Levodopa Sales by Type (2021-2026) & (MT)
Table 34. Global Levodopa Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Levodopa Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Levodopa Price by Type (2016-2021e) & (USD/Kg)
Table 37. Global Levodopa Price by Type (2021-2026) & (USD/Kg)
Table 38. Global Levodopa Sales by Application (2016-2021e) & (MT)
Table 39. Global Levodopa Sales by Application (2021-2026) & (MT)
Table 40. Global Levodopa Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Levodopa Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Levodopa Price by Application (2016-2021e) & (USD/Kg)
Table 43. Global Levodopa Price by Application (2021-2026) & (USD/Kg)
Table 44. North America Levodopa Sales by Country (2016-2021e) & (MT)
Table 45. North America Levodopa Sales by Country (2021-2026) & (MT)
Table 46. North America Levodopa Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Levodopa Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Levodopa Sales by Type (2016-2021e) & (MT)
Table 49. North America Levodopa Sales by Type (2021-2026) & (MT)
Table 50. North America Levodopa Sales by Application (2016-2021e) & (MT)
Table 51. North America Levodopa Sales by Application (2021-2026) & (MT)
Table 52. Europe Levodopa Sales by Country (2016-2021e) & (MT)
Table 53. Europe Levodopa Sales by Country (2021-2026) & (MT)
Table 54. Europe Levodopa Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Levodopa Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Levodopa Sales by Type (2016-2021e) & (MT)
Table 57. Europe Levodopa Sales by Type (2021-2026) & (MT)
Table 58. Europe Levodopa Sales by Application (2016-2021e) & (MT)
Table 59. Europe Levodopa Sales by Application (2021-2026) & (MT)
Table 60. Asia-Pacific Levodopa Sales by Region (2016-2021e) & (MT)
Table 61. Asia-Pacific Levodopa Sales by Region (2021-2026) & (MT)
Table 62. Asia-Pacific Levodopa Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Levodopa Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Levodopa Sales by Type (2016-2021e) & (MT)
Table 65. Asia-Pacific Levodopa Sales by Type (2021-2026) & (MT)
Table 66. Asia-Pacific Levodopa Sales by Application (2016-2021e) & (MT)
Table 67. Asia-Pacific Levodopa Sales by Application (2021-2026) & (MT)
Table 68. South America Levodopa Sales by Country (2016-2021e) & (MT)
Table 69. South America Levodopa Sales by Country (2021-2026) & (MT)
Table 70. South America Levodopa Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Levodopa Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Levodopa Sales by Type (2016-2021e) & (MT)
Table 73. South America Levodopa Sales by Type (2021-2026) & (MT)
Table 74. South America Levodopa Sales by Application (2016-2021e) & (MT)
Table 75. South America Levodopa Sales by Application (2021-2026) & (MT)
Table 76. Middle East & Africa Levodopa Sales by Country (2016-2021e) & (MT)
Table 77. Middle East & Africa Levodopa Sales by Country (2021-2026) & (MT)
Table 78. Middle East & Africa Levodopa Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Levodopa Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Levodopa Sales by Type (2016-2021e) & (MT)
Table 81. Middle East & Africa Levodopa Sales by Type (2021-2026) & (MT)
Table 82. Middle East & Africa Levodopa Sales by Application (2016-2021e) & (MT)
Table 83. Middle East & Africa Levodopa Sales by Application (2021-2026) & (MT)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Levodopa Typical Distributors
Table 87. Levodopa Typical Customers
List of Figures
Figure 1. Levodopa Picture
Figure 2. Global Levodopa Sales Market Share by Type in 2020
Figure 3. 0.98
Figure 4. 0.99
Figure 5. Others
Figure 6. Global Levodopa Sales Market Share by Application in 2020
Figure 7. Pharmaceuticals Industry
Figure 8. Dietary Supplements
Figure 9. Global Levodopa Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 10. Global Levodopa Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Levodopa Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Levodopa Sales (2016-2026) & (MT)
Figure 31. Global Levodopa Production Capacity (2016-2026) & (MT)
Figure 32. Global Levodopa Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Levodopa Market Drivers
Figure 34. Levodopa Market Restraints
Figure 35. Levodopa Market Trends
Figure 36. Global Levodopa Sales Market Share by Manufacturer in 2020
Figure 37. Global Levodopa Revenue Market Share by Manufacturer in 2020
Figure 38. Levodopa Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Levodopa Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Levodopa Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Levodopa Sales Market Share by Region (2016-2026)
Figure 42. Global Levodopa Revenue Market Share by Region (2016-2026)
Figure 43. North America Levodopa Revenue (2016-2026) & (USD Million)
Figure 44. Europe Levodopa Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Levodopa Revenue (2016-2026) & (USD Million)
Figure 46. South America Levodopa Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Levodopa Revenue (2016-2026) & (USD Million)
Figure 48. Global Levodopa Sales Market Share by Type (2016-2026)
Figure 49. Global Levodopa Revenue Market Share by Type (2016-2026)
Figure 50. Global Levodopa Price by Type (2016-2026) & (USD/Kg)
Figure 51. Global Levodopa Sales Market Share by Application (2016-2026)
Figure 52. Global Levodopa Revenue Market Share by Application (2016-2026)
Figure 53. Global Levodopa Price by Application (2016-2026) & (USD/Kg)
Figure 54. North America Levodopa Sales Market Share by Country (2016-2026)
Figure 55. North America Levodopa Revenue Market Share by Country (2016-2026)
Figure 56. North America Levodopa Sales Market Share by Type (2016-2026)
Figure 57. North America Levodopa Sales Market Share by Application (2016-2026)
Figure 58. Europe Levodopa Sales Market Share by Country (2016-2026)
Figure 59. Europe Levodopa Revenue Market Share by Country (2016-2026)
Figure 60. Europe Levodopa Sales Market Share by Type (2016-2026)
Figure 61. Europe Levodopa Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Levodopa Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Levodopa Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Levodopa Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Levodopa Sales Market Share by Application (2016-2026)
Figure 66. South America Levodopa Sales Market Share by Country (2016-2026)
Figure 67. South America Levodopa Revenue Market Share by Country (2016-2026)
Figure 68. South America Levodopa Sales Market Share by Type (2016-2026)
Figure 69. South America Levodopa Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Levodopa Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Levodopa Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Levodopa Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Levodopa Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
パーキンソン病の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease. Scope of the Report: This report focuses on the Parkinsons disease Drug in global market, especially in North America…- 世界の一般ウェルビーイング栄養補助食品市場 2021：企業別、地域別、種類・用途別 The General Well-Being Dietary Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のL-カルニチンサプリメント市場 2021：企業別、地域別、種類・用途別 The L-Carnitine Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- プロバイオティクス栄養補助食品の世界市場2018-2025 Probiotics are healthy microorganisms that help to maintain health when taken in sufficient amount.The rising awareness of the benefits of probiotic supplements to be one of the primary growth factors for the probiotic dietary supplements market. In 2018, the global Probiotic Dietary Supplements mar…
- 世界の高エネルギーサプリメント市場 2021：企業別、地域別、種類・用途別 The High Energy Supplements market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…